Politics Business Finance Economy Analysis World
Admin Subscribe
Truth, Without Favour  ·  Est. 2025
National Herald
Home Politics Business Finance Economy Analysis Opinion World Technology Health UK News Science Environment Education History
About Us Contact Subscribe Editorial Standards
Breaking
BP Annual Results: Profits Boosted by Iran War Oil Spike Despite Climate Pledge Tensions·Bellway Shares Slump 18% as Iran War Tears Up Housing Market Outlook·Bank of England Holds Rates at 4.5% as Iran War Reverses Cut Timeline·Arctic Ice Reaches Record Low Extent as Climate Scientists Issue Stark Warning·200,000 Patients Now on GLP-1 Weight Loss Drugs as NHS Rolls Out Obesity Treatment·13 Million Britons Living in Relative Poverty — Half a Million More Than Previous Year· BP Annual Results: Profits Boosted by Iran War Oil Spike Despite Climate Pledge Tensions·Bellway Shares Slump 18% as Iran War Tears Up Housing Market Outlook·Bank of England Holds Rates at 4.5% as Iran War Reverses Cut Timeline·Arctic Ice Reaches Record Low Extent as Climate Scientists Issue Stark Warning·200,000 Patients Now on GLP-1 Weight Loss Drugs as NHS Rolls Out Obesity Treatment·13 Million Britons Living in Relative Poverty — Half a Million More Than Previous Year·

Search results for "semaglutide"

2 results found

200,000 Patients Now on GLP-1 Weight Loss Drugs as NHS Rolls Out Obesity Treatment
Health
200,000 Patients Now on GLP-1 Weight Loss Drugs as NHS Rolls Out Obesity Treatment
The expansion of GLP-1 prescribing has put extraordinary demand on the system, with 400,000 patients on waitin…
Matthew Prescott · 11 May 2026
 Obesity Drugs on the NHS: Who Qualifies, What They Do, and What Comes Next
Health
Obesity Drugs on the NHS: Who Qualifies, What They Do, and What Comes Next
GLP-1 drugs like Wegovy are the most significant medical breakthrough in obesity treatment in decades. Nationa…
Dr. Priya Sharma, Health Correspondent · 9 Apr 2026